About Tiens Biotech Group (USA), Inc.

Tiens Biotech Group (USA), Inc. (AMEX: TBV) conducts
its business operations from Tianjin, People's
Republic of China. Tiens primarily engages in the
research, development, manufacturing, and marketing of
nutrition supplement products, including wellness
products and dietary nutrition supplement products,
and personal care products.

Tiens derives its revenues principally from product
sales to affiliated companies in China and
internationally in 52 countries. Since its
establishment, Tiens has developed and produced 33
nutrition supplements, which include wellness products
and dietary supplements. Tiens develops its products
at its own product research and development center,
which employs highly qualified professionals in the
fields of pharmacology, biology, chemistry and fine
chemistry. Tiens has obtained all required
certificates and approvals from government regulatory
agencies to manufacture and sell its products in
China.

In China, Tiens conducts the marketing and sales of
its products through its affiliated company, Tianshi
Engineering. Tianshi Engineering markets and sells
Tiens' products in China through chain stores,
domestic affiliated companies, and its 100 branches.
Outside of China, Tiens sells its products to
affiliated companies in 52 countries who in turn sell
through an extensive direct sales force, or
multi-level marketing sales force. The Company's
direct sales marketing program is subject to
governmental regulation in each of these countries.

Certain statements in this press release constitute
"forward-looking statements" within the meaning of
Section 27A of the Securities Act of 1933 and Section
21E of the Securities and Exchange Act of 1934. Such
forward- looking statements are not necessarily
indicative of future financial results, and may
involve known and unknown risks, uncertainties and
other factors, which may cause the actual results,
performance or achievements of the Company, to be
materially different from any future results,
performance, or achievements expressed or implied by
such forward-looking statements. The Company's future
operating results are dependent upon many factors,
including but not limited to: (i) the Company's
ability to obtain sufficient capital or a strategic
business arrangement to fund its expansion plans; (ii)
the Company's ability to build the management and
human resources and infrastructure necessary to
support the growth of its business; (iii) competitive
factors and developments beyond the Company's control;
(iv) whether the Company continues to experience
delays in the export clearance of its products; (v)
whether Tianshi Engineering, the Company's affiliate
which sells its products in China, obtains a direct
selling license in China; and (vi) other risk factors
discussed in the Company's periodic filings with the
Securities and Exchange Commission which are available
for review at http://www.sec.gov under "Search for
Company Filings."